Skip to main content
. 2022 Oct 21;21(3):789–796.e1. doi: 10.1016/j.cgh.2022.10.015

Table 3.

Characteristics of Patients With FGID/DGBI

Subject no. Age (y)/sex Type of FGID/DGBI D-Xylose, g/5 g/5 h (positive) Hydrogen breath test Hemoglobin (g/dL) Albumin (g/dL) B12 (pg/mL) UGIE with biopsy
1 35/M IBS-C 0.55 Negative 15.5 5.3 432 Normal
2 68/M Functional dyspepsia 0.62 Negative 13.1 3.5 362 Normal
3 42/F FAB/D 0.91 Negative 13.3 4.1 214 Normal
4 (IMO) 20/F IBS-M/FD 0.76 Methane producer 13.3 4.4 224 Normal
5 23/M Functional diarrhea 0.88 Negative 15.0 5.3 240 Normal
6 40/F IBS-D/FD 0.23 Negative 12.3 4.3 450 Normal
7 36/F IBS-M 0.42 Negative 12.3 4.1 1492 Normal
8 46/F Functional dyspepsia 0.88 Negative 14.0 4.9 422 Normal
9 (MAS) 37/M Functional dyspepsia 0.96 Negative 13.8 4.1 186 Normal

FAB/D, functional abdominal bloating/distention; FD, functional dyspepsia; IBS-C, irritable bowel syndrome-constipation; IBD-D, irritable bowel syndrome-diarrhea; IBS-M, irritable bowel syndrome-mixed; IMO, intestinal methanogen overgrowth; MAS, malabsorption syndrome; UGIE, upper gastrointestinal endoscopy.